Peptide Library

FDA-approved

Sexual & reproductive

Cetrorelix

Evidence

FDA approved

Class

GnRH antagonist

/

Cetrorelix

KEY TAKEAWAY

Cetrorelix is a ten-amino-acid synthetic GnRH antagonist. It is sold as Cetrotide. The FDA approved cetrorelix (Cetrotide) in 2000 for preventing premature luteinizing hormone surges in women having controlled ovarian stimulation.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

GnRH antagonist

Approved for

Preventing early ovulation during assisted reproduction

Key fact

The FDA approved cetrorelix (Cetrotide) in 2000 for preventing premature luteinizing hormone surges in women having controlled ovarian stimulation.

Route

Daily subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Cetrorelix is a ten-amino-acid synthetic GnRH antagonist. It is sold as Cetrotide.

How it works

How it works

It blocks GnRH receptors in the pituitary gland, which prevents a premature surge of luteinizing hormone during fertility treatment.

Regulatory status

Regulatory status

The FDA approved cetrorelix (Cetrotide) in 2000 for preventing premature luteinizing hormone surges in women having controlled ovarian stimulation.

What it is used for

What it is used for

Preventing early ovulation during assisted reproduction.

Side effects and risks

Side effects and risks

Injection-site reactions and nausea are common. Ovarian hyperstimulation syndrome can occur during fertility treatment.

Citations

Citations

U.S. FDA prescribing information for Cetrorelix. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo